FILTER
Refine your search with the following facets to narrow down your results.
- genes 3
- inhibitors 3
- liver cancer 3
- lung cancer 3
- medicine 3
- Bayer 2
- Novartis 2
- Wilex 2
- biomarker 2
- diagnostics 2
- diseases 2
- food 2
- gene expression 2
- growth factors 2
- hypertension 2
- interferon 2
- milestone payments 2
- pathology 2
- phase III studies 2
- proteins 2
- renal cell carcinomas 2
- Axitinib 1
- Bayer HealthCare 1
- DNA methylation 1
- Multi-Cancer Early Detection 1
- Orphan Drug Designation 1
- Orphan Drug Status 1
- RNA 1
- Roche 1
- Wilms’ tumours 1
- Wyeth 1
- amino acids 1
- angiogenesis 1
- antibodies 1
- approvals 1
- avelumab 1
- biomarkers 1
- blood 1
- blood analysis 1
- blood cancer 1
- blood disorders 1
- blood tests 1
- brain tumors 1
- breast cancer 1
- calcium 1
- cancer diagnostics 1
- cancer drugs 1
- cancer genes 1
- cancer stem cells 1
- cancer therapy 1
- cancer vaccines 1
- cell division 1
- chemical shift 1
- chemotherapy 1
- chromatin 1
- cystine 1
- diabetes 1
- drinking water 1
- fertility 1
- fluorine 1
- gefitinib 1
- genetics 1
- high blood pressure 1
- histology 1
- histones 1
- immunization 1
- isotopes 1
- kidney diseases 1
- kinase inhibitors 1
- license agreements 1
- liver 1
- longevity 1
- low birth weight 1
- magnetic resonance imaging 1
- medical devices 1
- metabolism 1
- metastasis 1
- methylation 1
- molecular medicine 1
- multiple myeloma 1
- mutations 1
- myelofibrosis 1
- nitric oxide 1
- nuclear medicine 1
- oncology 1
- oral cancer 1
- organoids 1
- organs 1
- ovarian cancer 1
- perfluorinated chemicals 1
- platinum 1
- polymers 1
- positron emission tomography 1
- pressure 1
- radiotherapy 1
- U. S. Food and Drug Administration (FDA) 3
- American Roentgen Ray Society 2
- Bayer Healthcare AG 2
- F. Hoffmann-La Roche AG 2
- Heidelberg Pharma AG 2
- Novartis International AG 2
- Onyx Pharmaceuticals, Inc. 2
- Antigenics Inc. 1
- Bayer AG 1
- Bayer Corporation 1
- Cancer Research UK 1
- Chalmers University of Technology 1
- Curacyte AG 1
- Duke University 1
- Eberhard-Karls-Universität Tübingen 1
- Fox Chase Cancer Center 1
- Huntsman Cancer Institute 1
- IBA Molecular 1
- IMBiotechnologies Ltd 1
- Imperial College of London 1
- Incyte Corporation 1
- Karolinska Institutet 1
- MC Services AG 1
- Massachusetts General Hospital 1
- Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch 1
- Merck KGaA 1
- Ohio State University 1
- OncoMethylome Sciences S.A. 1
- Paladin Labs Inc. 1
- Pfizer Inc. 1
- Sechenov First Moscow State Medical University 1
- University College London (UCL) 1
- University of Mississippi 1
- University of Notre Dame 1
- University of Oxford 1
- Wellcome Trust Sanger Institute 1
- Wyeth 1
- Wyeth Pharmaceuticals 1
- immatics Biotechnologies GmbH 1
27 Current news about the topic kidney cancer
FILTERS
Refine your search with the following facets to narrow down your results.
- genes 3
- inhibitors 3
- liver cancer 3
- lung cancer 3
- medicine 3
- Bayer 2
- Novartis 2
- Wilex 2
- biomarker 2
- diagnostics 2
- diseases 2
- food 2
- gene expression 2
- growth factors 2
- hypertension 2
- interferon 2
- milestone payments 2
- pathology 2
- phase III studies 2
- proteins 2
- renal cell carcinomas 2
- Axitinib 1
- Bayer HealthCare 1
- DNA methylation 1
- Multi-Cancer Early Detection 1
- Orphan Drug Designation 1
- Orphan Drug Status 1
- RNA 1
- Roche 1
- Wilms’ tumours 1
- Wyeth 1
- amino acids 1
- angiogenesis 1
- antibodies 1
- approvals 1
- avelumab 1
- biomarkers 1
- blood 1
- blood analysis 1
- blood cancer 1
- blood disorders 1
- blood tests 1
- brain tumors 1
- breast cancer 1
- calcium 1
- cancer diagnostics 1
- cancer drugs 1
- cancer genes 1
- cancer stem cells 1
- cancer therapy 1
- cancer vaccines 1
- cell division 1
- chemical shift 1
- chemotherapy 1
- chromatin 1
- cystine 1
- diabetes 1
- drinking water 1
- fertility 1
- fluorine 1
- gefitinib 1
- genetics 1
- high blood pressure 1
- histology 1
- histones 1
- immunization 1
- isotopes 1
- kidney diseases 1
- kinase inhibitors 1
- license agreements 1
- liver 1
- longevity 1
- low birth weight 1
- magnetic resonance imaging 1
- medical devices 1
- metabolism 1
- metastasis 1
- methylation 1
- molecular medicine 1
- multiple myeloma 1
- mutations 1
- myelofibrosis 1
- nitric oxide 1
- nuclear medicine 1
- oncology 1
- oral cancer 1
- organoids 1
- organs 1
- ovarian cancer 1
- perfluorinated chemicals 1
- platinum 1
- polymers 1
- positron emission tomography 1
- pressure 1
- radiotherapy 1
- U. S. Food and Drug Administration (FDA) 3
- American Roentgen Ray Society 2
- Bayer Healthcare AG 2
- F. Hoffmann-La Roche AG 2
- Heidelberg Pharma AG 2
- Novartis International AG 2
- Onyx Pharmaceuticals, Inc. 2
- Antigenics Inc. 1
- Bayer AG 1
- Bayer Corporation 1
- Cancer Research UK 1
- Chalmers University of Technology 1
- Curacyte AG 1
- Duke University 1
- Eberhard-Karls-Universität Tübingen 1
- Fox Chase Cancer Center 1
- Huntsman Cancer Institute 1
- IBA Molecular 1
- IMBiotechnologies Ltd 1
- Imperial College of London 1
- Incyte Corporation 1
- Karolinska Institutet 1
- MC Services AG 1
- Massachusetts General Hospital 1
- Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch 1
- Merck KGaA 1
- Ohio State University 1
- OncoMethylome Sciences S.A. 1
- Paladin Labs Inc. 1
- Pfizer Inc. 1
- Sechenov First Moscow State Medical University 1
- University College London (UCL) 1
- University of Mississippi 1
- University of Notre Dame 1
- University of Oxford 1
- Wellcome Trust Sanger Institute 1
- Wyeth 1
- Wyeth Pharmaceuticals 1
- immatics Biotechnologies GmbH 1